AlphaCore Capital »

Lenz Therapeutics shares owned by AlphaCore Capital

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by AlphaCore Capital from 13F filings

Historical chart of AlphaCore Capital investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by AlphaCore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by AlphaCore Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $160k 10k 16.00

More positions owned by AlphaCore Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Meta Platforms Cl A (META)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Schwab Strategic Tr Fundamental Us L (FNDX)
MPLX Com Unit Rep Ltd (MPLX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Fundamental Intl (FNDF)
Apple (AAPL)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Call Option (MSFT)
Etf Ser Solutions Distillate Us (DSTL)
Wisdomtree Tr Intl Qulty Div (IQDG)

View all positions for AlphaCore Capital

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics